RxDoctor Payments Data

Chaitanya Desai, MD

Nephrology · Peoria, ILNPI 1508090234

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $108,005 of the $132,352 with a category attached, or 81.6%. 6 manufacturers reported payments, led by Lilly USA, LLC at 48.9% of the total. Reporting peaked in 2024 at $90,761 and has fallen 60.3% since, to $36,062 in 2025. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$132,352in general payments, 2019–2025

Across 129 payments — averaging $1025.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$65K
  • Boehringer Ingelheim$62K
  • Travere Therapeutics, Inc.$5K
  • Dendreon Pharmaceuticals LLC$226
  • Abbott$167
  • E.r. Squibb & Sons, L.L.C.$33

What the payments were for

  • Consulting fees$10,0208%
  • Speaking & faculty fees$108,00582%
  • Travel & lodging$11,3469%
  • Food & beverage$2,9812%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$132,352 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.

See all nephrology providers in Illinois

Medicare billing

Part B allowed, 2024
$195,406
Medicare patients
293
Services billed
1,397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide45$100,811
Sevelamer Carbonate39$6,961
Hydralazine Hcl15$187
Losartan Potassium11$141
Prednisone24$128
Lisinopril15$81
Furosemide11$19
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$12

Paid to pharmacies, not to this prescriber.

Other nephrology in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →